Opthea Ltd: Opthea Participate in Citi 2024 Global Healthcare Conference
Opthea Ltd: Initial Director's Interest Notice
Opthea Ltd: Opthea Received A$15.9 Million R&D Tax Incentive
Opthea Ltd: Results of Meeting
Opthea Ltd: Director Appointment/Resignation
Opthea Ltd: Chair's Address to Shareholders
Opthea Ltd: Opthea's Wet AMD Program Featured at Ophthalmology Events
Opthea Ltd: Update Opthea Participates in November Investor Conferences
Opthea Ltd: Opthea to Participate in November Investor Conferences
Opthea Ltd: Quarterly Activities/Appendix 4C Cash Flow Report
Opthea Ltd: Opthea Corporate Presentation - Oct 2024
Opthea Ltd: Notice of Annual General Meeting/Proxy Form
Opthea Ltd: Opthea Files Notice of Annual General Meeting
Opthea Ltd: Opthea Wet AMD Program to be Presented at Innovate Retina
Opthea Ltd: Opthea Appoints Chief Medical and Chief Financial Officer
Opthea Ltd: Becoming a substantial holder
Opthea Ltd: Opthea to participate in UBS Virtual Ophthalmology Day 2024
Opthea Ltd: Opthea EURetina Symposium 2024
Opthea Ltd: Opthea Joins the S&P/ASX 300 Index
Opthea Ltd: Opthea Announces Completion of Drug Substance Campaign
No Data
No Data